Prevention And Management Of Dermatological Toxicities Related To Anticancer Agents: ESMO Clinical Practice Guidelines

    November 2020 in “ Annals of Oncology ”
    Mario E. Lacouture, V. Sibaud, Peter Arne Gerber … Karin Jordan
    Studysummary These guidelines discuss prevention and management strategies for dermatological toxicities but report no new clinical results; they include expert recommendations for conditions like acneiform rash and hand-foot syndrome.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on annalsofoncology.org →
    Discuss this study in the Community →

    Research cited in this study 7

    1. Hair Disorders in Patients with Cancer Journal of The American Academy of Dermatology · 2018
    2. Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer JAMA Dermatology · 2018
    3. Dermatological Adverse Events with Taxane Chemotherapy European Journal of Dermatology · 2016
    4. Cutaneous Adverse Effects of Targeted Therapies Journal of the American Academy of Dermatology · 2015
    5. Alopecia With Endocrine Therapies in Patients With Cancer Oncologist · 2013
    6. Pathobiology of Chemotherapy-Induced Hair Loss The Lancet Oncology · 2013
    7. Chemotherapy-Induced Dermatological Toxicity: Frequencies and Impact on Quality of Life in Women’s Cancers. Results of a Prospective Study Supportive care in cancer · 2007